Quanterix QTRX 深 滬
已收盤 12-19 16:00:00 美东时间
6.59
-0.210
-3.09%
華盛通- 最 高6.82
- 今 開6.77
- 成交量 117.13万股
- 最 低 6.515
- 昨 收 6.80
- 總市值 2.56亿
- 52周最高 12.4063
- 市盈率 靜 --
- 換手率 3.01%
- 52周最低 4.05
- 委 比 -49.29%
- 總股本 3885.49万
- 歷史最高 92.57
- 量 比 2.05
- 振 幅 4.49%
- 歷史最低 4.05
- 每 手 1
- 風險率 1.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Quanterix Publishes A Landmark Study In The Journal Brain; Study Demonstrates Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
Quanterix Corporation(NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the publication of a landmark study in the high-impact journal
11-18 06:38
Quanterix Affirms FY2025 Sales Guidance of $130.000M-$135.000M vs $133.465M Est
Quanterix (NASDAQ:QTRX) affirms FY2025 sales outlook from $130.000 million-$135.000 million to $130.000 million-$135.000 million vs $133.465 million estimate.
11-11 05:02
Quanterix Q3 EPS $(0.73) Misses $(0.38) Estimate, Sales $40.233M Beat $37.845M Estimate
Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.38) by 92.11 percent. This is a 231.82 percent decrease over losses of $(0.22) per share from the
11-11 05:01
快讯 | Quanterix Corp重申2025年收入预期为1.3亿至1.35亿美元。
Quanterix Corp - Reiterates 2025 Revenue Guidance of $130-$135 Mln
11-11 05:01
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Quanterix Q3 Earnings Preview
Quanterix (QTRX) is scheduled to announce Q3 earnings results on Monday, November 10th, after market close. The consensus EPS Estimate is -$0.53 and the consensus Revenue Estimate is $37.84M. Over the...
11-08 06:35
Earnings Preview For Quanterix
Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on ...
11-08 03:05
Quanterix Approves Key Governance Changes at Annual Meeting
Quanterix ( ($QTRX) ) just unveiled an update. On September 29, 2025, Quanterix...
10-03 04:48
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test
Shares of Quanterix Corp. are up ~4% in Wednesday morning trading after CMS' recently released preliminary Clinical Lab Fee Schedule listed the company's LucentAD Alzheimer blood biomarker test priced...
09-10 23:56
